Mariette L.
- Country
- The Netherlands
- Department
- Oncology
Research Overview
- Evaluation of Tumor Microenvironment Alterations Following Intradermal Ipilimumab and Intravenous Nivolumab Combination Therapy in Patients with Unresectable Stage III-IV Melanoma
- Combination Therapy of Monobenzone and Imiquimod with Standard Care for Advanced or Metastatic Malignant Melanoma
- Phase 2 Multicenter Study of Patritumab Deruxtecan in Patients with Locally Advanced or Metastatic Solid Tumors
Data & Insights
Has run more than one trial at 31 of 125 partner sites.
Specializations
Solid Tumor Research
This investigator specializes in treating patients with advanced and metastatic solid tumors, conducting innovative therapeutic interventions across multiple disease stages.
- Locally advanced tumors
- Metastatic disease management
- Unresectable tumor treatment
Their work encompasses comprehensive approaches to solid tumor therapy, including targeted treatment strategies.
Hematologic Oncology
The investigator's expertise extends to blood-based malignancies, with particular focus on multiple myeloma and non-Hodgkin lymphoma treatment modalities.
- Multiple myeloma therapy
- Non-Hodgkin lymphoma management
- Advanced hematologic interventions
Their research integrates targeted therapeutic approaches for hematological malignancies.
Precision Medicine
The investigator develops personalized treatment strategies based on genomic and protein expression variants, utilizing targeted anti-cancer drugs.
- Genomic-guided therapy
- Protein expression analysis
- Drug sensitivity prediction
Their approach incorporates molecular profiling to optimize treatment selection and patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.